Needham analyst upgrades Viavi Solutions to Buy with $15 price target after strong quarterly results. Fiscal Q3 revenue and margin outlook also raised.
Atlassian shares jumped 20% in extended trading Thursday after the software company issued an upbeat revenue outlook amid robust demand for its AI-powered cloud offerings. Monitor theses important ...
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...